BioMab, Inc. is an immune-based precision medicine company based in Taiwan. Spun-out of Academia Sinica, our current product portfolio focuses on two primary areas of precision medicine: circulating tumor cell (CTC) and cell therapy. BioMab Inc. focuses on immune-technology based products and aims to be the largest medium and reagent supplier in the cell therapy industry in Taiwan. The company‘s products have been recognized by many domestic and international customers. BioMab Inc. also works with many prestigious research institutions domestically and internationally for development and research.